ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Studies Are Demonstrating Effectiveness Of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 12, 1974

In Brief: NIH Conference To Explore Conflict Of Interest Issues; Five NCUI Executive Win PHS Awards

May 26, 1989

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study

March 6, 1992

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983